- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06816563
Prediction of Version Outcomes for External Maneuvers of Breech Fetus by Assessment of Breech Progression Angle (ECV)
Prediction of Version Outcomes for External Maneuvers of Breech Fetus by Assessment of Breech Progression Angle (breech Progression Angle)
Study Overview
Status
Conditions
Detailed Description
Patients will be recruited before starting the cephalic version for external maneuvers. An ultrasound evaluation will be performed for each patient before the external maneuver version of breech fetus; specifically, the following will be performed:
- Transabdominal ultrasound for evaluation of the following parameters: type of breech presentation, estimated fetal weight (according to Hadlock), maximum amniotic fluid flap, position of the placenta (anterior/posterior or fundic), angle between the fetal spine at the cervical level and the fetal occiput (occipital-spine angle).
- Transperineal ultrasound for evaluation of the following parameters: Breech Progression Angle (BPA), Subpubic Arch (SPA).
If the external maneuver version is successful, an additional transperineal ultrasound will be performed for evaluation of Angle of Progression (AoP).
After delivery, data will be recorded regarding mode of delivery, indication for operative delivery (in case of cesarean section or obstetric suction), neonatal arterial and venous pH, possible admission to the NICU. These data will be collected by consulting the medical records of recruited patients. The population will be recruited as part of the normal care pathway.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Aly Mohamed Alaaeldin Kamaleldin Aly Youssef, MD
- Phone Number: 0512144412
- Email: aly.youssef@aosp.bo.it
Study Locations
-
-
-
Bologna, Italy, 40138
- Recruiting
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
-
Contact:
- Aly Mohamed Alaaeldin Kamaleldin Aly Youssef, MD
- Phone Number: 0512144412
- Email: aly.youssef@aosp.bo.it
-
Bologna, Italy, 40133
- Recruiting
- Ospedale Maggiore Carlo Alberto Pizzardi
-
Contact:
- Maria Segata, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Women >18 years of age with a single pregnancy at term (37-42 gestational weeks) with a fetus in breech presentation
- Acquisition of Informed Consent Form
Exclusion Criteria:
- Oligohydramnios: maximum flap < 2cm
- Placenta previa
- Uterine malformations
- Regular uterine dynamics
- Metrorrhagia
- Contraindications to vaginal delivery
- Premature rupture of membranes
- Nonreassuring cardiotocographic tracing
- Previous uterine surgery
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of new ultrasound indexes (Breech Progression Angle, BPA)
Time Frame: During the ultrasound performed before the version for external maneuvers of breech fetus
|
Evaluation using transperineal ultrasonography, the role of a new ultrasound index (Breech Progression Angle, BPA) in predicting the success of external maneuver version of breech fetus
|
During the ultrasound performed before the version for external maneuvers of breech fetus
|
Collaborators and Investigators
Investigators
- Principal Investigator: Aly Mohamed Alaaeldin Kamaleldin Aly Youssef, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ECV
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breech Presentation
-
Chelsea and Westminster NHS Foundation TrustUnknownPresentation; Breech, Complicating PregnancyUnited Kingdom
-
Herning HospitalCompletedPresentation; Breech, With External Version Before Labor
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingCesarean Section | Vaginal Delivery | Breech Fetal Presentation | Breech Presentation of Fetus with Successful Version
-
Region SkaneSuspended
-
Nantes University HospitalCompletedBreech Presentation in PregnancyFrance
-
Johann Wolfgang Goethe University HospitalUnknown
-
Hadassah Medical OrganizationCompletedBreech Presentation; Before LaborIsrael
-
Rambam Health Care CampusRecruitingBreech Presentation of Fetus With Successful VersionIsrael
-
Hadassah Medical OrganizationUnknown
-
University Hospital, GrenobleCompletedBreech Fetal PresentationFrance